These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 24359781)

  • 1. Synthesis and β-adrenergic blocking activity of oxime ether hybrids derived from a natural isochroman-4-one.
    Bai RR; Xu ST; Liu J; Hong W; Tang YQ; Wu XM; Xie WJ; Yao HQ; Xu JY
    Chin J Nat Med; 2013 Sep; 11(5):538-45. PubMed ID: 24359781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel hybrids of natural isochroman-4-one bearing N-substituted isopropanolamine as potential antihypertensive candidates.
    Bai R; Huang X; Yang X; Hong W; Tang Y; Yao H; Jiang J; Liu J; Shen M; Wu X; Xu J
    Bioorg Med Chem; 2013 May; 21(9):2495-502. PubMed ID: 23538234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel nitric oxide-releasing isochroman-4-one derivatives: Synthesis and evaluation of antihypertensive activity.
    Bai R; Yang X; Zhu Y; Zhou Z; Xie W; Yao H; Jiang J; Liu J; Shen M; Wu X; Xu J
    Bioorg Med Chem; 2012 Dec; 20(23):6848-55. PubMed ID: 23084434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, synthesis and biological evaluation of isochroman-4-one hybrids bearing piperazine moiety as antihypertensive agent candidates.
    Xie S; Li X; Yu H; Zhang P; Wang J; Wang C; Xu S; Wu Z; Liu J; Zhu Z; Xu J
    Bioorg Med Chem; 2019 Jul; 27(13):2764-2770. PubMed ID: 31078380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis and biological evaluation of hydrogen sulfide-releasing isochroman-4-one derivatives as new antihypertensive agent candidates.
    Wu H; Li X; He C; Liu Y; Wang C; Yang X; Ma F; Liu J; Xu J
    Bioorg Med Chem; 2022 Jun; 64():116776. PubMed ID: 35483137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and adrenergic activity of a new series of N-aryl dicyclopropyl ketone oxime ethers: SAR and stereochemical aspects.
    Blanc M; Tamir A; Aubriot S; Michel MC; Bouzoubaa M; Leclerc G; Demenge P
    J Med Chem; 1998 May; 41(10):1613-8. PubMed ID: 9572886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis, docking study and β-adrenoceptor activity of some new oxime ether derivatives.
    Ghabbour HA; El-Bendary ER; El-Ashmawy MB; El-Kerdawy MM
    Molecules; 2014 Mar; 19(3):3417-35. PubMed ID: 24658567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and pharmacological properties of nebivolol, a new antihypertensive compound.
    Van Lommen G; De Bruyn M; Schroven M
    J Pharm Belg; 1990; 45(6):355-60. PubMed ID: 1982295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Synthesis and bioactivity of some 3,4-diacyloxybenzopyrans].
    Yan Z; Huang WL; Peng SX; Hua WY
    Yao Xue Xue Bao; 1997; 32(2):97-105. PubMed ID: 11243208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Indenopyrazole oxime ethers: synthesis and β1-adrenergic blocking activity.
    Angelone T; Caruso A; Rochais C; Caputo AM; Cerra MC; Dallemagne P; Filice E; Genest D; Pasqua T; Puoci F; Saturnino C; Sinicropi MS; El-Kashef H
    Eur J Med Chem; 2015 Mar; 92():672-81. PubMed ID: 25618014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. First total synthesis of antihypertensive natural products S-(+)-XJP and R-(-)-XJP.
    Wang C; Wei G; Yang X; Yao H; Jiang J; Liu J; Shen M; Wu X; Xu J
    Org Biomol Chem; 2014 Oct; 12(37):7338-44. PubMed ID: 25116266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on agents with vasodilator and beta-blocking activities. I.
    Seki T; Takezaki T; Ohuchi R; Ohuyabu H; Ishimori T; Yasuda K
    Chem Pharm Bull (Tokyo); 1994 Aug; 42(8):1609-16. PubMed ID: 7954913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Some new derivatives of aromatic oximes with beta-blocking activity].
    Martani A; Magli M; Orzalesi G; Selleri R
    Farmaco Sci; 1975 May; 30(5):370-9. PubMed ID: 240738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis, and biological activity of oxime ether strobilurin derivatives containing indole moiety as novel fungicide.
    Xie YQ; Huang ZL; Yan HD; Li J; Ye LY; Che LM; Tu S
    Chem Biol Drug Des; 2015 Jun; 85(6):743-55. PubMed ID: 25346294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and beta-adrenergic blocking activity of new aliphatic and alicyclic oxime ethers.
    Bouzoubaa M; Leclerc G; Decker N; Schwartz J; Andermann G
    J Med Chem; 1984 Oct; 27(10):1291-4. PubMed ID: 6148422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and beta-adrenergic blocking activity of a novel class of aromatic oxime ethers.
    Leclerc G; Mann A; Wermuth CG; Bieth N; Schwartz J
    J Med Chem; 1977 Dec; 20(12):1657-62. PubMed ID: 22751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The synthesis and biological evaluation of a range of novel functionalized benzopyrans as potential potassium channel activators.
    Tyrrell E; Tesfa KH; Greenwood I; Mann A
    Bioorg Med Chem Lett; 2008 Feb; 18(3):1237-40. PubMed ID: 18191566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis, stereochemistry, and antimicrobial evaluation of substituted piperidin-4-one oxime ethers.
    Ramalingan C; Park YT; Kabilan S
    Eur J Med Chem; 2006 Jun; 41(6):683-96. PubMed ID: 16600438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta-adrenoreceptor blocking heterocyclic oximes and ethers.
    Manna F; Chimenti F; Bolasco A; Lena R; Filippelli A; Falciani M; Fontana M
    Farmaco; 1996 Nov; 51(11):699-706. PubMed ID: 9035376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and beta-adrenoreceptor blocking activity of [[3-(alkylamine)-2-hydroxypropyl]oximino]pyridines and O[3-(alkylamine)-2-hydroxypropyl]methylpyridine ketone oximes derivatives.
    Manna F; Bolasco A; Bizzarri B; Lena R; Chimenti F; Filippelli A; Palla A; Fontana M
    Farmaco; 1996; 51(8-9):579-87. PubMed ID: 8930111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.